Haemonetics Corp (NYSE:HAE)
| 89.53 Delayed Data As of Sep 29 |  -1.63 / -1.79%Today’s Change | 72.26 Today|||52-Week Range 95.26 | +13.83% Year-to-Date |
Latest HAE News | Press Releases
Today’s Trading
| Previous close | 91.16 |
| Today’s open | 91.21 |
| Day’s range | 89.24 - 92.59 |
| Volume | 336,066 |
| Average volume (3 months) | 292,354 |
| Market cap | $4.5B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +167.44% |
| Earnings growth (this year) | +18.32% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +17.67% |
| P/E ratio | 33.7 |
| Price/Sales | 3.64 |
| Price/Book | 5.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MMSIMerit Medical System... | -0.39 | -0.56% |
| GKOSGlaukos Corp | -0.95 | -1.25% |
| ---- | ||
| IARTIntegra Lifesciences... | -0.29 | -0.75% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | $0.88 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | $115.4M |
| Net profit margin | 9.87% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
